Literature DB >> 14532153

Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis.

E Choy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14532153      PMCID： PMC1766748          DOI： 10.1136/ard.62.suppl_2.ii68

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.

Authors:  S Kotake; K Sato; K J Kim; N Takahashi; N Udagawa; I Nakamura; A Yamaguchi; T Kishimoto; T Suda; S Kashiwazaki
Journal:  J Bone Miner Res       Date:  1996-01       Impact factor: 6.741

2.  Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

Authors:  E H S Choy; D A Isenberg; T Garrood; S Farrow; Y Ioannou; H Bird; N Cheung; B Williams; B Hazleman; R Price; K Yoshizaki; N Nishimoto; T Kishimoto; G S Panayi
Journal:  Arthritis Rheum       Date:  2002-12

3.  Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys.

Authors:  M Mihara; M Kotoh; N Nishimoto; Y Oda; E Kumagai; N Takagi; K Tsunemi; Y Ohsugi; T Kishimoto; K Yoshizaki; Y Takeda
Journal:  Clin Immunol       Date:  2001-03       Impact factor: 3.969

4.  Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis.

Authors:  A Boe; M Baiocchi; M Carbonatto; R Papoian; O Serlupi-Crescenzi
Journal:  Cytokine       Date:  1999-12       Impact factor: 3.861

Review 5.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.

Authors:  B Dasgupta; M Corkill; B Kirkham; T Gibson; G Panayi
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

7.  Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody.

Authors:  A F Kavanaugh; H Schulze-Koops; L S Davis; P E Lipsky
Journal:  Arthritis Rheum       Date:  1997-05

Review 8.  The use of knockout mice to understand the role of cytokines in fever.

Authors:  M J Kluger; W Kozak; L R Leon; C A Conn
Journal:  Clin Exp Pharmacol Physiol       Date:  1998-02       Impact factor: 2.557

Review 9.  Interleukin-6 and its receptor in autoimmunity.

Authors:  T Kishimoto
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

10.  Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  N Takagi; M Mihara; Y Moriya; N Nishimoto; K Yoshizaki; T Kishimoto; Y Takeda; Y Ohsugi
Journal:  Arthritis Rheum       Date:  1998-12
View more
  6 in total

1.  Induction of IL-6 expression by mechanical stress in the trabecular meshwork.

Authors:  Paloma B Liton; Coralia Luna; Marc Bodman; Anna Hong; David L Epstein; Pedro Gonzalez
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

2.  RTD-1 therapeutically normalizes synovial gene signatures in rat autoimmune arthritis and suppresses proinflammatory mediators in RA synovial fibroblasts.

Authors:  Prasad Tongaonkar; Vasu Punj; Akshay Subramanian; Dat Q Tran; Katie K Trinh; Justin B Schaal; Teresina Laragione; André J Ouellette; Percio S Gulko; Michael E Selsted
Journal:  Physiol Genomics       Date:  2019-11-25       Impact factor: 4.297

3.  Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy.

Authors:  Takako Miyamae; David E Malehorn; Bonnie Lemster; Masaaki Mori; Tomoyuki Imagawa; Shumpei Yokota; William L Bigbee; Manda Welsh; Klaus Klarskov; Norihiro Nishomoto; Abbe N Vallejo; Raphael Hirsch
Journal:  Arthritis Res Ther       Date:  2005-04-04       Impact factor: 5.156

4.  Krüppel-Like Factor 4 Is a Regulator of Proinflammatory Signaling in Fibroblast-Like Synoviocytes through Increased IL-6 Expression.

Authors:  Xinjing Luo; Jie Chen; Jianwei Ruan; Yongfeng Chen; Xuanrong Mo; Jiangwen Xie; Guoju Lv
Journal:  Mediators Inflamm       Date:  2016-06-16       Impact factor: 4.711

5.  Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells.

Authors:  Paloma B Liton; Guorong Li; Coralia Luna; Pedro Gonzalez; David L Epstein
Journal:  Mol Vis       Date:  2009-02-11       Impact factor: 2.367

Review 6.  Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development.

Authors:  Hooi-Yeen Yap; Sabrina Zi-Yi Tee; Magdelyn Mei-Theng Wong; Sook-Khuan Chow; Suat-Cheng Peh; Sin-Yeang Teow
Journal:  Cells       Date:  2018-10-09       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.